Amidst the rising corona virus cases in India, good news has also started coming about its medicine. The pharmaceutical company Mylan NV said on Monday that it will launch a generic version of the antiviral drug Remedisvir of Gilead Sciences' corona virus in India. The company said that its price will be Rs 4,800, which is 80 percent less than the developed countries.
4
$
@mahonali3
posted
4 years ago
That's really a good news for Covid patients in India. But even Rs 4,800 is high for poor people.